Assessment of left ventricular systolic function has a central role in the evaluation of cardiac disease. Accurate assessment is essential to guide management and prognosis. Numerous echocardiographic techniques are used in the assessment, each with its own advantages and disadvantages. This review is based on a literature search of the PubMed, MEDLINE, EMBASE, and Scopus databases from inception through December 30, 2017, using the terms strain echocardiography, tissue Doppler strain, and speckle-tracking echocardiography. We provide the internist with a contemporary overview of current echocardiographic techniques used in the evaluation of left ventricular systolic function. In particular, we focus on the role of speckle-tracking echocardiography, including its utility in the detection of subclinical left ventricular dysfunction and the associated prognostic implications. 
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The 3-dimensional (3-D) arrangement of myocardial fiber bundles in the ventricular myocardium is complex, with fibers arranged to maximize the efficiency of cardiac contraction. Myocardial fibers are arranged in a helical and perpendicular orientation, with clockwise epicardial and counterclockwise subendocardial fibers ( Figure 1A ). 2, 3 This orthogonal fiber orientation causes opposing directions of rotation at the left ventricular (LV) base and apex, resulting in a "wringing-like" cardiac emptying effect during ventricular systole. 4 Most cardiac myofibers are oriented in the circumferential direction, with a proportionally smaller number oriented in a longitudinal direction. 5 The ratio of circumferential to longitudinal fibers is approximately 10:1 in canine models, with a higher proportion of circumferential fibers at the base and a lower proportion at the cardiac apex. 5 Myofiber orientation varies throughout the myocardial wall, with a predominantly oblique fiber orientation in the subepicardium, transverse fiber orientation in the midmyocardium, and longitudinal fiber orientation in the subendocardium ( Figure 1B ).
Herein we review the conventional assessment of LV systolic function and examine the role of speckle-tracking echocardiography (STE), a new method to assess LV function. We also highlight the role of STE in the assessment and management of cardiac and noncardiac disease, including detection of subclinical LV dysfunction. To provide a contemporary overview of STE and its clinical applications, we conducted a literature search of the PubMed, MEDLINE, EMBASE, and Scopus databases from inception through December 31, 2017, using the search terms strain echocardiography, tissue Doppler strain, and speckle-tracking echocardiography.
LV SYSTOLIC FUNCTION AND PROGNOSIS
Assessment of LV systolic function is a central part of the evaluation of cardiac disease. Numerous methods can be used in this assessment (Table) . 6 Accurate assessment of LV function is important for guiding patient management and prognosis, and it is essential in the evaluation of patients with known or suspected cardiac disease.
Numerous large multicenter trials, including the Multicenter Postinfarction Research Group, 7 the Coronary Artery Surgery Study Registry, 8 the GISSI-3 trial, 9 and the Digitalis Intervention Group, 10 have reported the close relationship between declining LV function and poorer prognosis. This relationship is related to the degree of LV systolic dysfunction and is independent of the imaging modality used in this assessment. 11 The Multicenter Postinfarction Research Group evaluated more than 850 patients after myocardial infarction and found that LV systolic dysfunction was associated with a 2.4-fold increase in the relative risk of death. 7 The substantially larger Coronary Artery Surgery Study Registry definitively demonstrated the adverse impact of LV dysfunction on prognosis in a study of more than 24,000 medically treated patients with coronary artery disease during median follow-up of 12 years. 8 Greater degrees of LV systolic dysfunction were associated with a worse prognosis. Survival was affected by LV ejection fraction (LVEF); 12-year survival was 21% for patients with an LVEF less than 35% and 54% for those with an LVEF of 35% to 49%. Both survival rates were markedly worse than that of patients with normal LV systolic function (12-year survival, 73%). 8 Despite considerable advances in medical therapy, more recent trials, including the GISSI-3 and Digitalis Intervention Group trials, continue to underscore the strong link between LV systolic dysfunction and mortality. 9, 10 The value of LV systolic function assessment extends far beyond patient prognostication. It has a vital role in defining the treatment and management of patients with cardiac disease. Numerous trials have found that various interventions in the setting of LV systolic dysfunction can improve the overall prognosis of cardiac patients. The CONSENSUS (Cooperative North Scandinavian Enalapril Survival Study) 12 found a 30% relative risk reduction for mortality with the use of angiotensin-converting enzyme inhibitors in patients with LV systolic dysfunction; the COPERNICUS (Carvedilol Prospective Randomized Cumulative Survival) Study 13 found a 35% risk reduction using carvedilol; the RALES (Randomized Aldactone Evaluation Study) 14 found a 30% risk reduction with spironolactone; and the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) investigators reported a 23% reduction in mortality with implantable cardiac defibrillator therapy. 15 These trials illustrate the importance of LV systolic function assessment. Not only is LV systolic function a marker of prognosis, it also strongly guides the establishment of appropriate, lifeprolonging therapy. d Strain echocardiography is a powerful predictor of cardiac mortality and morbidity for numerous cardiac conditions; it provides additional prognostic information over ejection fraction assessment alone.
ARTICLE HIGHLIGHTS
d Current imaging guidelines recommend routine echocardiographic assessment of strain for follow-up of oncology patients after chemotherapy.
CONVENTIONAL ASSESSMENT OF LV FUNCTION Linear Dimensions
Assessment of LV function with M-mode or 2-dimensional (2-D) echocardiography ( Figure 2A ) can be performed in the parasternal long-and short-axis views by placing the calipers perpendicular to the ventricular long axis. Change in LV cavity dimensions during systole can be used to calculate LV fractional shortening and ejection fraction. The major limitation of this technique occurs in patients with regional LV dysfunction because assessment of ventricular systolic function in 2 opposing basal segments is unlikely to provide an accurate reflection of overall LV function. Inaccuracies can result from the geometric assumptions used in the Teichholz or Quinones methods to calculate LVEF from linear ventricular dimensions. In addition, cardiac orientation often results in difficulties in attaining perpendicular alignment of the M-mode beam with the LV long axis. Hence, current echocardiographic guidelines no longer recommend using linear measurements to calculate LVEF. 6 Doppler Assessment of Stroke Volume Cardiac stroke volume can be estimated by multiplying the velocity-time integral obtained from Doppler examination of the LV outflow tract by the LV outflow tract area ( Figure 2B ). Doppler examination requires parallel alignment of the pulse-wave beam with the LV outflow tract. Nonparallel beam alignment can result in a reduced LV stroke volume by underestimating the velocity-time integral. Furthermore, this method requires accurate estimation of the LV outflow tract diameter; minor inaccuracies in diameter estimation result in marked errors in the area calculation because of the squaring of the radius.
Rate of Ventricular Pressure Rise
Calculation of the rate of ventricular pressure rise uses continuous-wave Doppler to 
Modified Simpson Biplane Method
The modified Simpson biplane method is the currently recommended method of quantifying LV volume and systolic function ( Figure 2D and E) . 16 This method calculates LV volume by manually tracking the LV endocardial border in 2 planes, the apical 4-chamber and the apical 2-chamber views. The LV is then approximated to a series of elliptical discs that are summated to determine LV volume. Assessment of the change in ventricular volumes between systole and diastole allows estimation of LVEF.
Although current echocardiographic guidelines recommend the modified Simpson biplane method to quantify LV volume and systolic function, this technique still has limitations, including suboptimal endocardial definition and extensive wall motion abnormalities. 6 Other technical challenges include geometric assumptions related to the use of 2 axes to globally assess LV function, adequate alignment of apical views without foreshortening, arrhythmias, and the influence of load-dependent factors on ventricular function assessment.
When endocardial definition is suboptimal, commercially available microbubble contrast agents may be used for image optimization ( Figure 2E ). These intravenously administered agents consist of an inert gas surrounded by a lipid or protein shell. The microbubbles are approximately the size of red blood cells and pass through the pulmonary vasculature to opacify the left-sided cardiac chambers. Echocardiographic contrast agents contain neither iodine nor gadolinium and may be safely administered to patients with renal impairment. Use of microbubble contrast improves endocardial border definition and improves correlation of 2-D volumetric assessment with cardiac magnetic resonance imaging (MRI), which is considered the reference standard for assessing LV systolic function because of its high spatial and temporal resolution. 17 
3-D Volumetric Assessment
Current echocardiographic guidelines recommend the use of 3-D echocardiography (in laboratories experienced in the use of this technique) to assess LV volume and systolic function ( Figure 2F ). 6 This technique allows acquisition of the entire LV in a single volumetric data set using either single-beat or multibeat acquisitions. Strong correlation with cardiac MRI has been reported because of the absence of geometric assumptions and foreshortening. 17 Limitations of this technique include suboptimal endocardial border definition and the influence of loaddependent factors.
STRAIN ECHOCARDIOGRAPHY
Given the limitations of these routine parameters, the complexity of LV systolic function is unlikely to be comprehensively addressed by the previously mentioned assessment methods alone. The more recent developments of tissue Doppler imaging and speckle-tracking imaging during the past decade have facilitated significant advances Rate of ventricular pressure rise (mm Hg/s) >1200
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in noninvasive assessment of myocardial mechanics and cardiac function. The initial development of tissue Doppler strain and strain rate imaging were early steps in the echocardiographic assessment of cardiac mechanics. These techniques used Doppler to assess myocardial motion and analyzed motion at 1 point relative to another in the myocardium. 18 Myocardial deformation, termed strain, was reported as a percentage change in length. 18, 19 Strain is a dimensionless index of myocardial deformation and can, hence, be defined as a vector acting in various directions: longitudinal, circumferential, radial, and twist or torsion. 18 However, despite the demonstrated clinical value of tissue velocity strain imaging, widespread clinical use was limited by analysis time, angle dependency, and considerable intraobserver and interobserver variability. 18, 19 The subsequent development of speckle tracking signified a new era in echocardiographic strain imaging. Speckle-tracking strain, a vector derived from Lagrangian strain, has 2 components: magnitude and direction of motion. This technique is based on tracking the movement of speckles generated by the interaction of ultrasound waves with the myocardium. 20, 21 Semiautomated tracking of clusters of speckles allows assessment of myocardial deformation and offers an angle-independent measure of strain. 20, 21 In addition, compared with tissue Doppler strain, this technique offers the clear advantages of easier and faster strain assessment. 20 Current STE techniques require the acquisition of standard parasternal and apical images. Global longitudinal strain (GLS) can be assessed from the apical window by using standard apical 4-chamber, 2-chamber, and long-axis images. Global circumferential strain (GCS) and global radial strain (GRS) can be assessed by using parasternal shortaxis imaging performed at the basal, mid, and apical levels. Each technique requires the operator to mark the endocardial and epicardial borders. Echocardiographic software then tracks the movement of echocardiographic speckles during myocardial contraction. During systole, the shortening of longitudinal and circumferential myocardial fiber length (assessed by GLS and GCS, respectively) is denoted by negative values. Systolic radial myocardial fiber thickening (assessed by GRS) is denoted by positive values. To avoid confusion caused by the use of positive and negative values, strain values can also be represented as absolute values and denoted in square brackets to avoid use of the negative sign.
Validation of 2-D STE
Compared with its predecessor, tissue Doppler imagingÀbased strain, 2-D STE is superior because of improved correlation with MRI, improved feasibility, and reduced interobserver and intraobserver variability. 22, 23 Assessment with 2-D STE has shown excellent correlation with the criterion standard of invasive sonomicrometry in animal models (r¼0.79-0.94). [24] [25] [26] Sonomicrometric assessment, performed by Amundsen et al, 26 suggested that long-axis strain assessment may be superior to short-axis assessments, with better correlation (r¼0.79 vs r¼0.90). In vivo assessment of human subjects, using a tagged MRI control, has also shown good correlation with 2-D STE. 22, 23, 27, 28 Twodimensional STE has been particularly useful in the assessment of regional wall motion abnormalities and scar tissue, with good sensitivity and specificity compared with cardiac MRI. 23, 27, 28 Comparison of 2-D STE and LVEF Left ventricular systolic function results from a combination of longitudinal and circumferential myofiber shortening. Global longitudinal strain assesses the function of longitudinally orientated myofibers, which are most vulnerable to myocardial disease because of their subendocardial location; GCS assesses circumferential myofibers, which are predominantly located in the midmyocardial wall and are typically affected in more clinically significant myocardial disease. Stokke et al 29 used mathematical modeling, validated by clinical echocardiographic data, to study the relationship of LVEF to STE. They found that each percentage change in GCS had a 1.6-fold larger effect on LVEF than did GLS. Hence, a reduction in GLS could be compensated by a smaller improvement in GCS to maintain the LVEF. Stokke et al 29 also reported that reduced LV cavity size or increased wall thickness diminished the longitudinal and circumferential shortening required to maintain the LVEF. In particular, a 1-cm increase in LV wall thickness or a 100-mL decrease in LV end-diastolic volume reduced the global systolic shortening required to maintain LVEF by 3.0 and 2.1 percentage points, respectively. Thus, in myocardial diseases with thickened walls or small ventricular cavities (eg, hypertrophic cardiomyopathy, cardiac amyloidosis), LVEF may be preserved despite reductions in GLS and GCS.
For patients with impaired LVEF, GLS and LVEF have a linear relationship, with a GLS of À11% or À12% corresponding to an LVEF of 35%. 30, 31 In contrast, GLS and LVEF have a curvilinear relationship in patients with normal LVEF. 31 Therefore, the ability of GLS to detect subclinical myocardial dysfunction is likely greatest for patients with normal LVEF, and the advantage of GLS over LVEF may be its sensitivity to detect early subclinical cardiomyopathy before LVEF declines.
Clinical Applications of 2-D STE
The clinical use of 2-D STE (Figure 3 ) in cardiac assessment is widespread, with demonstrated benefit in various cardiac conditions, including assessment of coronary ischemia, assessment and prognostication of cardiomyopathies (ischemic and nonischemic), differentiation of hypertrophy, assessment of valvular heart disease, and monitoring of patients receiving cardiotoxic chemotherapy. Two-dimensional GLS is a powerful predictor of cardiac mortality and morbidity in various cardiac conditions, with 2-D GLS and 2-D GCS providing additional prognostic information over LVEF assessment alone. 30, 32 Two-dimensional GLS remains the predominant tool for clinical application because of its ease of use, reproducibility, time efficiency, and simplicity. Currently, GCS and GRS have limited clinical application and are predominantly research tools.
Two-dimensional GLS can predict allcause mortality in unselected patients undergoing echocardiography, with 2-D GLS providing the greatest additional benefit (hazard ratio [HR], 1.45) over clinical variables compared with LVEF (HR, 1.23) and wall motion score index (HR, 1.28). The incremental value of 2-D GLS is greatest in patients with normal or mildly impaired LV systolic function (ie, LVEF >35%), with 2-D GLS being a valuable predictor of allcause mortality, regardless of whether patients had wall motion abnormalities. 30 Two-dimensional STE also is a useful tool for assessing patients with congestive cardiac failure because GLS and GCS can predict the risk of adverse cardiac outcomes, including heart failure readmissions and cardiac mortality. Cho et al 32 reported that GLS and GCS values less negative than À10.3% and À10.7%, respectively, were associated with an increased incidence of rehospitalization for heart failure and cardiac mortality in patients with acute heart failure. In patients with advanced heart failure, the addition of STE to traditional electrocardiographic parameters provides added value when assessing the likelihood of response to cardiac resynchronization therapy; this form of pacemaker therapy can improve outcomes for patients with advanced heart failure, who respond positively to this therapy. Prospective, multicenter studies have found that STE-assessed radial, circumferential, and transverse strain are useful in determining the presence of mechanical dyssynchrony and in predicting response to cardiac resynchronization therapy (defined as >15% relative increase in LVEF, >5% absolute increase in LVEF, or >15% decrease in LV end-diastolic volume), even for patients with known electrical dyssynchrony (QRS prolongation). [33] [34] [35] In addition, the absence of mechanical dyssynchrony by STE was associated with a more than 4-fold increase in cardiac events, including mortality, need for cardiac transplant, and need for an LV assist device. 35 Speckle-tracking echocardiography has also been found to be useful in guiding placement of the LV device lead in cardiac resynchronization therapy, with lead placement in the region of latest contraction by peak radial strain being associated with an improvement in mortality rate and heart failure admissions. 36 Two-dimensional GLS is a useful adjunct tool in patients undergoing dobutamine stress echocardiography. It confers high sensitivity and diagnostic accuracy for the assessment of clinically significant coronary stenosis compared with coronary angiography. 37 When used in combination with the wall motion score index, 2-D GLS offers greater sensitivity, specificity, and diagnostic accuracy compared with either technique (ie, 2-D GLS or wall motion score index alone). 37 A recent retrospective study by Montgomery et al 38 suggests that resting 2-D GLS alone may provide comparable sensitivity and specificity to the wall motion scoring during stress imaging for the detection of hemodynamically significant nonobstructive coronary stenoses, with a 2-D GLS of À17.77% providing the optimal balance between sensitivity and specificity. Strain analysis during dobutamine stress echocardiography has been proven to be reproducible, especially global 2-D GLS. 39 In the setting of ischemic heart disease, the prognostic value of 2-D GLS has been reported in patients with myocardial infarction and in those with chronic ischemic cardiomyopathy.
Early echocardiographic evaluation of ST-elevation myocardial infarction by 2-D GLS is a good predictor of mortality and postinfarct events, including future myocardial infarction, stroke, and congestive heart failure. 40, 41 When performed within 24 hours of hospital presentation, 2-D GLS is superior to LVEF and to indexed LV end-systolic volume as a prognostic marker. 40 The value of 2-D GLS was reported by Munk et al, 40 who placed patients into 3 arbitrary groups and found that those with a 2-D GLS more negative than À15% had the best prognosis, whereas those with a 2-D GLS less negative than À10% had a high risk of adverse outcomes (HR of 4.6 for the combined end point of death, myocardial infarction, stroke, and heart failure). Deterioration in 2-D GLS by more than 10% at 3 days postreperfusion, compared with before reperfusion, is associated with a markedly worse prognosis, with 36% of patients in this group dying or being hospitalized for heart failure within 6 months. 41 For patients with suspected non-ST elevation acute coronary syndromes and normal initial cardiac biomarkers at presentation, GLS can predict the presence of clinically significant coronary artery stenosis; a GLS more negative than À21% excludes coronary artery disease, with a high negative predictive value of 92%. 42 In patients with chronic ischemic cardiomyopathy, 2-D GLS is also a strong independent predictor of all-cause mortality and hospitalization for heart failure, with a 5% increase in 2-D GLS being associated with an HR of 1.69 for death and an HR of 1.64 for the combination of death and hospitalization for heart failure. 43 Speckle-tracking echocardiography is also a good predictor of infarct size and myocardial viability in patients with previous myocardial infarction. Gjesdal et al 44 reported that after a myocardial infarction, GLS better predicted infarct size compared with gadolinium-enhanced cardiac MRI, wherein a GLS less negative than À15% identified a clinically significant infarction (sensitivity and specificity of 83% and 93%, respectively). In addition, in their study, regional strain less negative than À13% detected transmural infarction (sensitivity and specificity of 80% and 83%, respectively). Two-dimensional GLS is also a useful bedside tool for assessing cardiac viability, correlating well with final infarct size by cardiac MRI (r¼0.67) when performed in the early postreperfusion setting. 45 The value of 2-D STE is not limited to global averaged values alone, however, and the pattern of regional variation provides additional value when assessing underlying cardiac disease (Figure 4 ). This is particularly evident in ischemic heart disease, for which qualitative wall motion scoring forms a routine part of echocardiographic assessment. Regional assessment of strain imaging quantitatively measures regional wall motion and can be used with resting and stress echocardiography. Furthermore, regional longitudinal strain can predict segmental viability with good sensitivity and specificity compared with cardiac MRI. 27 Regional strain pattern analysis can be useful to identify various specific nonischemic cardiomyopathies. Regional strain analysis is valuable for differentiating between the various pathologic conditions that can cause increased ventricular wall thickness. Strain is markedly reduced in hypertrophic cardiomyopathy, only mildly reduced in hypertensive hypertrophy, and preserved in the physiologic hypertrophy of an adaptive athlete's heart. 46 Increased wall thickness due to cardiac amyloidosis causing infiltrative cardiomyopathy has a specific apicalsparing pattern. 47 Two-dimensional STE is also useful in the setting of valvular heart disease, where it is a sensitive marker of subclinical LV systolic dysfunction. Two-dimensional GLS is a strong independent predictor of mortality and major adverse cardiac events in this setting. [48] [49] [50] [51] Its ability to identify subclinical LV dysfunction in mitral and aortic valve disease makes it potentially useful in guiding the timing of intervention in patients with uncertain or absent symptoms. 48, 50, 51 Kearney et al 48 reported very poor 1-year survival (25%) free of major adverse cardiac events in patients with aortic stenosis who had a 2-D GLS less negative than À15%, with a 30-fold increase in all-cause mortality compared with age-matched controls. Twodimensional GLS has been found to be superior to the conventional parameters of LVEF and aortic valve area in predicting outcomes of aortic stenosis. 48 In the setting of mitral regurgitation, de Isla et al 50 reported that 2-D GLS is a more sensitive and specific marker of subclinical LV dysfunction than is LVEF. Furthermore, in patients with degenerative mitral regurgitation who have normal LV size and systolic function, Magne et al 52 reported a 14% increase in the risk of adverse cardiac events for every 1% decrease in 2-D GLS. In addition, 2-D GLS assessment before valve replacement (surgical and transcatheter aortic valve replacement) predicts long-term outcomes. 49, 53 The ability of GLS to identify early subclinical cardiomyopathy and prognosis in patients with asymptomatic valvular heart disease has the potential to add additional value to determining the optimal timing for surgical intervention, but more research is needed before this assessment can be incorporated into clinical practice.
Sequential assessment of LV function is central in the monitoring of patients receiving chemotherapy. Onset of LV dysfunction should prompt immediate alteration of the chemotherapeutic regimen because of the associated cardiotoxicity. For such patients, early detection of ventricular dysfunction is imperative. Twodimensional GLS is a sensitive early marker of LV dysfunction, with a decline in 2-D GLS preceding a decrease in LVEF ( Figure 5 ). [54] [55] [56] Stoodley et al 54 reported a decline in 2-D STE parameters of greater than 10% in almost half of their cohort of patients receiving anthracycline chemotherapy. No patient was reported to have a similar decline in LVEF, suggesting that subclinical LV dysfunction is quite common. 54 Poterucha et al 56 further found that subclinical LV dysfunction, manifest as a decline in 2-D GLS, preceded overt LV dysfunction. This finding is not limited to anthracycline cardiotoxicity, as similar effects are seen with other cardiotoxic chemotherapeutic agents, such as trastuzumab. 55 These findings illustrate the potentially important role of STE in the routine assessment of patients receiving chemotherapy. An expert consensus statement has been issued by the American Society of Echocardiography and the European Association of Cardiovascular Imaging to support the routine clinical use of 2-D GLS in the serial monitoring of chemotherapy-induced cardiotoxicity. A cutoff value of relative reduction in 2-D GLS of 15% was identified as being highly specific and sensitive for cardiotoxicity. The value of 2-D GLS has also been reported in various other clinical settings, including after cardiac surgery and cardiac transplant. Two-dimensional GLS is a useful predictor of postsurgical cardiac outcomes, with a reduction in 2-D GLS predicting increased risk of postoperative mortality. 58 This method of assessment is particularly useful in patients with a preserved LVEF because a reduction in 2-D GLS is a marker of prolonged inotropic support requirement and of postoperative mortality. 58 In the postÀcardiac transplant setting, although GLS is frequently reduced, a 2-D GLS less negative than À9% in the early posttransplant period was associated with a significantly increased 1-year mortality rate. 59 Thus, this ability to detect subclinical LV dysfunction makes 2-D STE a valuable tool in the assessment of all cardiac patients. It has the potential to better define prognosis and, hence, alter patient management to improve prognosis in patients with subclinical disease.
THREE-DIMENSIONAL STE
The recent development of 3-D STE allows calculation of LVEF, volumetric analysis, and simultaneous measurement of multidirectional components of strain in a single 3-D data set. This method may overcome the potential limitations of 2-D STE, such as out-of-plane motion tracking of speckles, which can increase noise and reduce accuracy. 60, 61 In addition, 3-D LVEF and volumetric assessment can overcome the geometric assumptions of 2-D imaging. 62 Similar to its predecessor, 3-D STE has also been validated by using tagged MRI and sonomicrometry as the reference standards. [63] [64] [65] Seo et al 64 compared 3-D STE with invasive sonomicrometry and found good correlation with global strain parameters (3-D GLS, r¼0.89; 3-D GRS, r¼0.84; 3-D GCS, r¼0.90). They conducted further sonomicrometric evaluation for 3-D global area strain, a novel parameter calculated from the percentage deformation of the endocardial surface area. 63 This parameter provided superior correlation compared with longitudinal or circumferential strain alone because it concurrently considered deformation in both longitudinal and circumferential directions. 63 Maffessanti and colleagues 65 reported poor intertechnique agreement between 2-D STE and 3-D STE, which was thought to represent the intrinsic limitations of 2-D STE in tracking out-of-plane motion.
Comparison with an MRI control group revealed superiority of 3-D STE over 2-D STE in regional wall motion assessment. 65 Luis et al 66 reported that 3-D STE correlates well with 2-D ejection fraction and 3-D ejection fraction and is not inferior to 2-D STE. In addition, image acquisition for 3-D STE is quicker than that for 2-D STE because the whole heart can be captured in a single apical view over 4 cardiac cycles. 66 Early clinical data demonstrate the clinical utility of 3-D STE. Recent work by Matsumoto et al 67 reported the value of 3-D GCS as an independent predictor of hospitalization and death in the setting of dilated cardiomyopathy. Superiority over 2-D STE parameters was found in assessment of contractile reserve in this group of patients, with a change in 3-D GCS with dobutamine being the only independent predictor of adverse cardiac events. 67 Limitations of STE The routine use of STE requires adequate training for physicians and sonographers. In contrast to older tissue Doppler imaging methods, newer speckle-tracking imaging has increased the ease of assessment, improved interobserver variability, and decreased analysis times. 39 Currently, no guidelines exist on the competency and training required for strain analysis. However, Chan et al 68 recently reported that a learning curve exists for 2-D GLS analysis, with a minimum of 50 studies recommended for accurate and reproducible reporting. This training is an important step toward quality control as the clinical use of 2-D GLS is becoming widespread. However, despite improvements in this technology, current techniques require up to approximately 5 minutes for image acquisition and analysis, which places a small additional time burden on already busy echocardiography laboratories. 66 Despite the widespread availability of STE techniques across multiple platforms, the lack of an agreed-on method for analysis provides some variability between available ultrasound systems. 22, 69 The degree of variability is incompletely defined and results in technical challenges in data interpretation. To overcome this, the American Society of Echocardiography and the European Association of Cardiovascular Imaging have formed a taskforce with industry partners to standardize strain imaging across the different vendors. 70, 71 This effort is ongoing, and although recent studies have found improvement in intervendor agreement, full compatibility has not yet been achieved. 71 Current STE techniques require adequate myocardial visualization and well-defined endocardial border definition to ensure reliable tracking of speckles with automated software. The main factor limiting strain analysis is inadequate image quality, with the recommendation of no more than 2 poorly visualized segments. In addition, the entire ventricular myocardium must be included in the imaging sector, which can pose particular challenges in the setting of severe ventricular dilatation.
Two-dimensional STE requires comparable heart rates and imaging frame rates from all 3 apical echocardiographic imaging planes for analysis, which limits the use of this technique in the setting of atrial fibrillation or a significant burden of ectopy. The use of 3-D echocardiography or triplane image acquisition may help overcome this limitation with the potential ability to image the LV in a single heartbeat.
CONCLUSION
Assessment of LV function remains the most common reason for cardiac imaging because of its powerful ability to predict morbidity and mortality. Current routine methods of quantifying LV function (with LVEF) is not without limitations. Strain imaging that uses speckle tracking in 2-D and 3-D offers promise for quantifying LV function, particularly for patients with borderline LV function, because of the potential to identify subclinical disease. Strain imaging offers the treating physician a unique opportunity to alter management before the onset of overt LV dysfunction, which may, in turn, improve prognosis. Although further investigation is yet required to define the role and usefulness of this technique for a range of cardiac conditions, strain imaging will undoubtedly have a meaningful role in the future of echocardiographic imaging. Technologic advances, including further reductions in analysis time and ease of use, are sure to bring this technique into routine clinical use.
Abbreviations and Acronyms: 2-D = 2-dimensional; 3-D = 3-dimensional; GCS = global circumferential strain; GLS = global longitudinal strain; GRS = global radial strain; HR = hazard ratio; LV = left ventricle; LVEF = left ventricular ejection fraction; MRI = magnetic resonance imaging; RV = right ventricle; STE = speckle-tracking echocardiography
